[HTML] thelancet.comFull View

[HTML][HTML] Concurrent driver gene mutations as negative predictive factors in epidermal growth factor receptor-positive non-small cell lung cancer

M Chen, Y Xu, J Zhao, W Zhong, L Zhang, Y Bi… - …, 2019 - thelancet.com
Abstract Background Tyrosine kinase inhibitors (TKIs) are clinically effective in non-small
cell lung cancer (NSCLC) patients harbouring epidermal growth factor receptor (EGFR) …
被引用次数：64 相关文章
[HTML] sciencedirect.com

[HTML][HTML] Concurrent Driver Gene Mutations as Negative Predictive Factors in Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer

M Chen, Y Xu, J Zhao, W Zhong, L Zhang, Y Bi… - EBioMedicine, 2019 - Elsevier
Abstract Background Tyrosine kinase inhibitors (TKIs) are clinically effective in non-small
cell lung cancer (NSCLC) patients harbouring epidermal growth factor receptor (EGFR) …

Concurrent Driver Gene Mutations as Negative Predictive Factors in Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer.

M Chen, Y Xu, J Zhao, W Zhong, L Zhang, Y Bi… - Ebiomedicine, 2019 - europepmc.org
Background Tyrosine kinase inhibitors (TKIs) are clinically effective in non-small cell lung
cancer (NSCLC) patients harbouring epidermal growth factor receptor (EGFR) oncogene …

Concurrent Driver Gene Mutations as Negative Predictive Factors in Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer

M Chen, Y Xu, J Zhao, W Zhong, L Zhang… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Tyrosine kinase inhibitors (TKIs) are clinically effective in non-small cell lung
cancer (NSCLC) patients harbouring epidermal growth factor receptor (EGFR) oncogene …
[HTML] nih.gov

[HTML][HTML] Concurrent Driver Gene Mutations as Negative Predictive Factors in Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer

M Chen, Y Xu, J Zhao, W Zhong, L Zhang, Y Bi… - …, 2019 - ncbi.nlm.nih.gov
Background Tyrosine kinase inhibitors (TKIs) are clinically effective in non-small cell lung
cancer (NSCLC) patients harbouring epidermal growth factor receptor (EGFR) oncogene …

[引用][C] Concurrent Driver Gene Mutations as Negative Predictive Factors in Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer

M Chen, Y Xu, J Zhao, W Zhong, L Zhang, Y Bi… - EBioMedicine, 2019 - cir.nii.ac.jp
Concurrent Driver Gene Mutations as Negative Predictive Factors in Epidermal Growth Factor
Receptor-Positive Non-Small Cell Lung Cancer | CiNii Research CiNii 国立情報学研究所 学術 …

Concurrent Driver Gene Mutations as Negative Predictive Factors in Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer.

M Chen, Y Xu, J Zhao, W Zhong, L Zhang, Y Bi… - Ebiomedicine, 2019 - europepmc.org
Background Tyrosine kinase inhibitors (TKIs) are clinically effective in non-small cell lung
cancer (NSCLC) patients harbouring epidermal growth factor receptor (EGFR) oncogene …